Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Aug;79(4):923–928. doi: 10.1111/j.1476-5381.1983.tb10537.x

Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.

B T Nguyen, S Stadtsbaeder
PMCID: PMC2044940  PMID: 6606459

Abstract

The antitoxoplasm effects of cotrimoxazole (Ctx), spiramycin (Spir) and pyrimethamine-sulphadiazine (Pmm-Sdz) were compared during both proliferative and chronic phases of infection of mice with the Beverley (Bev) strain of Toxoplasma gondii of low virulence. The therapeutic efficacy of the drugs was determined according to the following criteria: (i) specific antibody response; (ii) acquired resistance to lethal challenge with the virulent RH strain of Toxoplasma; and (iii) persistence of parasites in tissues (brain, liver, spleen) of treated mice. The results indicated that Ctx, like Pmm-Sdz, had a greater effect than Spir upon toxoplasma organisms during the proliferative phase of infection. In contrast, none of the three drugs tested was active against tissue cysts in chronically infected mice.

Full text

PDF
923

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEVERLEY J. K. A rational approach to the treatment of toxoplasmic uveitis. Trans Opthal Soc U K. 1958;78:109–121. [PubMed] [Google Scholar]
  2. Beverley J. K., Henry L. Histopathological changes caused by congenital toxoplasmosis in mice. Lyon Med. 1971 May 9;225(9):883–887. [PubMed] [Google Scholar]
  3. Bommer W., Höfling K. H., Heunert H. H. [Multiplication of toxoplasma gondii in cell cultures]. Ger Med Mon. 1969 Aug;14(8):399–405. [PubMed] [Google Scholar]
  4. Bushby S. R., Hitchings G. H. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother. 1968 May;33(1):72–90. doi: 10.1111/j.1476-5381.1968.tb00475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. COOK M. K., JACOBS L. In vitro investigations on the action of pyrimethamine against Toxoplasma gondii. J Parasitol. 1958 Jun;44(3):280–288. [PubMed] [Google Scholar]
  6. Frenkel J. K. Advances in the biology of sporozoa. Z Parasitenkd. 1974;45(2):125–162. doi: 10.1007/BF00348532. [DOI] [PubMed] [Google Scholar]
  7. Frisch J. M. Clinical experience with adverse reactions to trimethoprim-sulfamethoxazole. J Infect Dis. 1973 Nov;128(Suppl):607–p. doi: 10.1093/infdis/128.supplement_3.s607. [DOI] [PubMed] [Google Scholar]
  8. GARIN J. P., EYLES D. E. Le traitement de la toxoplasmose expérimentale de la souris par la spiramycine. Presse Med. 1958 May 28;66(42):957–958. [PubMed] [Google Scholar]
  9. Jones T. C., Len L., Hirsch J. G. Assessment in vitro of immunity against Toxoplasma gondii. J Exp Med. 1975 Feb 1;141(2):466–482. doi: 10.1084/jem.141.2.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LAINSON R. Observations on the development and nature of pseudocysts and cysts of Toxoplasma gondii. Trans R Soc Trop Med Hyg. 1958 Sep;52(5):396–407. doi: 10.1016/0035-9203(58)90123-8. [DOI] [PubMed] [Google Scholar]
  11. Nguyen B. T., Stadtsbaeder S. In vitro activity of cotrimoxazole on the intracellular multiplication of Toxoplasma gondii. Pathol Eur. 1975;10(4):307–315. [PubMed] [Google Scholar]
  12. SOURANDER P., LYCKE E., LUND E. Observations on living cells infected with Toxoplasma gondii. Br J Exp Pathol. 1960 Apr;41:176–178. [PMC free article] [PubMed] [Google Scholar]
  13. Sander J., Midtvedt T. The effect of trimethoprim on acute experimental toxoplasmosis in mice. Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(6):664–668. doi: 10.1111/j.1699-0463.1970.tb04355.x. [DOI] [PubMed] [Google Scholar]
  14. Sheffield H. G., Melton M. L. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures. J Parasitol. 1975 Aug;61(4):704–712. [PubMed] [Google Scholar]
  15. Stadtsbaeder S., Calvin-Preval M. C. L'association trimethoprim + sulfamethoxazole au cours de la toxoplasmose experimentale chez la souris. Acta Clin Belg. 1973;28(1):34–39. doi: 10.1080/17843286.1973.11716852. [DOI] [PubMed] [Google Scholar]
  16. Stadtsbaeder S., Nguyen B. T., Calvin-Preval M. C. Respective role of antibodies and immune macrophages during acquired immunity against toxoplasmosis in mice. Ann Immunol (Paris) 1975 Jun-Jul;126C(4):461–474. [PubMed] [Google Scholar]
  17. Stadtsbaeder S., Nguyen Etude de l'immunité anti-toxoplasme chez les souris athymiques congénitales nu/nu. Ann Immunol (Paris) 1977 Jan-Mar;128(1-2):149–150. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES